Provided by Tiger Trade Technology Pte. Ltd.

LAEKNA-B

15.000
-0.010-0.07%
Volume:945.50K
Turnover:14.08M
Market Cap:6.69B
PE:-22.33
High:15.410
Open:15.100
Low:14.680
Close:15.010
52wk High:23.500
52wk Low:8.100
Shares:446.00M
HK Float Shares:446.00M
Volume Ratio:0.38
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.672
ROE:-23.10%
ROA:-13.75%
PB:4.98
PE(LYR):-22.33
PS:55.05

Loading ...

LAEKNA-B (02105) Enters Exclusive Licensing Agreement with Qilu Pharma for LAE 002 (Afuresertib) in China

Stock News
·
Nov 12, 2025

Laekna (2105.HK) Announces Exclusive License Agreement with Qilu Pharma for Afuresertib in the China Region

Bulletin Express
·
Nov 12, 2025

Laekna Grants Qilu Pharma Exclusive License for LAE002 in China

Reuters
·
Nov 12, 2025

Laekna Inc - Entitled to Receive up to RMB530 Mln Upon Nda Approval

THOMSON REUTERS
·
Nov 12, 2025

Laekna Inc - Qilu Pharma Granted Exclusive License for Lae002 in China

THOMSON REUTERS
·
Nov 12, 2025

Laekna, Inc. (02105) Releases Monthly Return for October 2025 with No Change in Issued Share Capital

Bulletin Express
·
Nov 06, 2025

LAE102 Opens Up New Horizons for Muscle Growth

Stock News
·
Oct 16, 2025

Insider Sellers Might Regret Selling Laekna Shares at a Lower Price Than Current Market Value

Simply Wall St.
·
Oct 11, 2025

Next Major BD Deal in Weight Loss Sector - Could LAEKNA-B (02105) Be the Biggest Winner?

Stock News
·
Oct 09, 2025

Stock Track | LAEKNA-B Soars 27.42% on Positive Phase I Results for Obesity Drug LAE102

Stock Track
·
Sep 29, 2025

LAEKNA-B (02105): Phase I Clinical MAD Study Achieves Positive Preliminary Results, LAE102 Demonstrates Encouraging Muscle-Building and Fat-Reducing Trends

Stock News
·
Sep 29, 2025

Laekna Inc. Announces Positive Preliminary Phase I Results for LAE102, Showing Increased Lean Body Mass and Reduced Fat Mass in Obesity Study

Reuters
·
Sep 29, 2025

Hong Kong Stock Movement | LAEKNA-B (02105) Surges Over 7% in Early Trading as Company Completes Placement Raising Net Proceeds of Approximately HK$577 Million for ActRII Product Portfolio Development

Stock News
·
Sep 26, 2025